CVC CORDATUS LOAN FUND XXVIII DESIGNATED ACTIVITY COMPANY
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Miscellaneous business Credit Institutions), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about CVC CORDATUS LOAN FUND XXVIII DESIGNATED ACTIVITY COMPANY
Live alerts from global media, monitored by Business Radar
2025-01-20 (businessupturn.com)
CVC Capital seeks to restructure $350 million loan after Sajjan India's revenue and profit plunge: Report |
CVC Capital is reportedly in discussions with lenders to restructure a $350 million loan taken for the leveraged buyout of Sajjan India in 2021. The company, now rebranded as Cohizon Life Sciences Ltd, has been facing severe headwinds, leading to a significant drop in its revenue and profitability, according to a report by Moneycontrol. Key […]
Read more
2024-08-05 (pharmaceutical-technology.com)
Mallinckrodt sells Therakos to CVC Capital Partners for $925m - Pharmaceutical Technology
Mallinckrodt emerged from bankruptcy in November 2023 after reducing its total funded debt by approximately $1.9bn.
Read more